Aelis Farma

ISIN: FR0014007ZB4 | Ticker: AELIS | LEI: 8945008D5R6WV7EXRN47

Sector: Health Care – Sub-Industry: Biotechnology

Country: France

About Aelis Farma

Company Description

Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases.

Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments.

These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology.

Year founded

2013

Headcount

Headquarters

Neurocentre François Magendie 146 Rue Léo Saignat, 33000 Bordeaux – France